Study Detail

COVID-19 Vacc Maternal Immunisation

Phase 2/3, Placebo-Controlled, Randomized, Observer-Blinded, Study to Evaluate to the Safety, Tolerability and Immunogenicity of SARS-CoV-2 RNA Vaccine Candidate (BNT162b2) against COVID-19 IN Healthy Pregnant Women 18 years of Age and Older.

Status: Open

Type: Interventional

Funder: Pfizer Inc.

Sponsor: Pfizer Inc.

CI: not available

IRAS-Number: 295903

CPMS-ID: 47718

Approval Date: 13 January 2021

Back to listing